Literature DB >> 18293274

Portal hypertension and gastrointestinal bleeding.

Jaime Bosch1, Juan G Abraldes, Annalisa Berzigotti, Juan Carlos Garcia-Pagan.   

Abstract

Variceal bleeding is one of the most serious complications of portal hypertension. The driving force for the development of varices is an increase in portal pressure. As portal hypertension progresses, varices dilate until they finally rupture and bleed. This sequence of events might be prevented by achieving a sufficient decrease in portal pressure or by acting locally at the varices with endoscopic treatments. This article reviews the rationale for the management of portal hypertension and the current recommendations for the prevention and treatment of variceal bleeding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18293274     DOI: 10.1055/s-2008-1040318

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  25 in total

Review 1.  Acute variceal bleeding: risk stratification and management (including TIPS).

Authors:  Virginia Hernández-Gea; Claudia Berbel; Anna Baiges; Juan C García-Pagán
Journal:  Hepatol Int       Date:  2017-06-20       Impact factor: 6.047

2.  Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option.

Authors:  Guilherme Lopes P Martins; Joao Paulo G Bernardes; Marcello S Rovella; Raphael G Andrade; Publio Cesar C Viana; Paulo Herman; Giovanni Guido Cerri; Marcos Roberto Menezes
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

3.  Pulmonary arterial hypertension: an unusual cause of portal hypertension.

Authors:  Enric Reverter; Susana Seijo; Jaime Bosch
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-06

4.  Non-invasive Diagnosis of Oesophageal Varices Using Systemic Haemodynamic Measurements by Finometry: Comparison with Other Non-invasive Predictive Scores.

Authors:  Kara Rye; Gerri Mortimore; Andrew Austin; Jan Freeman
Journal:  J Clin Exp Hepatol       Date:  2016-05-13

5.  Diagnostic non-invasive model of large risky esophageal varices in cirrhotic hepatitis C virus patients.

Authors:  Hatem Elalfy; Walid Elsherbiny; Ashraf Abdel Rahman; Dina Elhammady; Shaker Wagih Shaltout; Ayman Z Elsamanoudy; Bassem El Deek
Journal:  World J Hepatol       Date:  2016-08-28

6.  The treatment of hepatic encephalopathy in the cirrhotic patient.

Authors:  Arun J Sanyal; Kevin D Mullen; Nathan M Bass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-04

Review 7.  Treatment of portal hypertension.

Authors:  Khurram Bari; Guadalupe Garcia-Tsao
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

8.  Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Jian-Bo Zhao; Chao Feng; Qiao-Hua Zhu; Xiao-Feng He; Yan-Hao Li; Yong Chen
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

9.  Determination of correlation of Adjusted Blood Requirement Index with outcome in patients presenting with acute variceal bleeding.

Authors:  Naheed Akhtar; Bader Faiyaz Zuberi; Syed Riazul Hasan; Raj Kumar; Salahuddin Afsar
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

10.  Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.

Authors:  Radan Bruha; Marie Jachymova; Jaromir Petrtyl; Karel Dvorak; Martin Lenicek; Petr Urbanek; Tomislav Svestka; Libor Vitek
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.